TENAX THERAPEUTICS, INC. 4
4 · TENAX THERAPEUTICS, INC. · Filed Dec 20, 2016
Insider Transaction Report
Form 4
Jebsen Michael B
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-12-15+150,000→ 150,000 totalExercise: $2.07Exp: 2026-12-15→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in four equal annual installments beginning on December 15, 2017.